Showing results (601-610 of 1,343) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|October 19, 2016
Systems genetics analysis of pharmacogenomics variation during antidepressant treatmentM B Madsen, L J A Kogelman, H N Kadarmideen, et al.The Pharmacogenomics Journal|March 5, 2014
Gene expression analysis in RA: towards personalized medicineA N Burska, K Roget, M Blits, et al.The Pharmacogenomics Journal|April 19, 2017
More than 25 years of genetic studies of clozapine-induced agranulocytosisS A J de With, S L Pulit, W G Staal, et al.The Pharmacogenomics Journal|April 12, 2017
Global genetic variation of select opiate metabolism genes in self-reported healthy individualsF R Wendt, G Pathak, A Sajantila, et al.The Pharmacogenomics Journal|April 12, 2017
SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han ChineseH Gui, M Kwok, L Baum, et al.The Pharmacogenomics Journal|January 18, 2017
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplantG N Almeida-Paulo, I Dapía García, R Lubomirov, et al.The Pharmacogenomics Journal|January 25, 2017
Genetic polymorphisms as predictive biomarker of survival in patients with gastrointestinal stromal tumors treated with sunitinibJ S L Kloth, M C Verboom, J J Swen, et al.The Pharmacogenomics Journal|March 19, 2008
Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: protective role of a functional polymorphism in the 3'-untranslated regionL Greenbaum, R C Smith, A Rigbi, et al.The Pharmacogenomics Journal|March 19, 2008
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatmentD F Heitjan, D A Asch, Riju Ray, et al.The Pharmacogenomics Journal|March 2, 2021
Development of a population pharmacokinetic model and Bayesian estimators for isoniazid in Tunisian tuberculosis patientsMohammed Alshaikheid, Nadia Ben Fredj, Ibtissem Hannachi, et al.Pageof 135